SlowBull
The Business Brief WEDNESDAY, 12 AUGUST 2026
← All stories
Markets

Psychedelics developer Definium scores more positive data for LSD pill

1 source ·1 article ·3h ago

Results from a late-stage study focused on generalized anxiety disorder were a “clean win” to analysts, who believe Definium has a drug with multibillion-dollar sales potential.

Covered by 1 outlet

Biopharmadive 1

All coverage · 1 article

BioPharma Dive ·3h ago

Psychedelics developer Definium scores more positive data for LSD pill

Results from a late-stage study focused on generalized anxiety disorder were a “clean win” to analysts, who believe Definium has a drug with multibillion-dollar sales potential.